Top Markets
Coin of the day
ICARES Medicus, Inc. ICARES Medicus, Inc.

ICARES Medicus, Inc.

6612
Rang in Aktien #21315
ICARES Medicus, Inc. operates as a dedicated nano-medical materials company,... ICARES Medicus, Inc. operates as a dedicated nano-medical materials company, engaging in the entire lifecycle from innovation and production to global distribution of advanced ophthalmic medical materials. Its core offerings encompass a range of ocular solutions, most notably intraocular lenses (IOLs) designed to correct visual impairments such as cataracts, nearsightedness (myopia), farsightedness (hyperopia), age-related vision loss (presbyopia), and astigmatism. Additionally, the company supplies sophisticated surgical implantation systems along with comprehensive technical support services. Established in 2011, ICARES Medicus, Inc. maintains its headquarters in Zhubei, Taiwan.
Aktienkurs
$2.33
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$110.19M
Veränderung (1 Tag)
-2.01%
Veränderung (1 Jahr)
-28.85%
Land
TW
Handel ICARES Medicus, Inc. (6612)

Kategorie

Dividendenrendite-Verlauf für ICARES Medicus, Inc. (6612)
Dividendenrendite (TTM) von ICARES Medicus, Inc. (Aktienkürzel: 6612) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für ICARES Medicus, Inc. (6612) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber